1,358
Participants
Start Date
September 30, 2010
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
MVI 200
Dose reservoir of 200 mcg of misoprostol in a hydrogel polymer vaginal insert within a retrieval system. The MVI 200 will be kept in place for up to 24 hours or will be removed earlier if one of the following occur: onset of active labor, intrapartum adverse event necessitating discontinuation of the study drug, other reasons including maternal request.
Dinoprostone Vaginal Insert (DVI)
Dose reservoir of 10 mg of dinoprostone in a hydrogel polymer vaginal insert within a retrieval system. The DVI will be kept in place for up to 24 hours or will be removed earlier if one of the following occur: onset of active labor, intrapartum adverse event necessitating discontinuation of the study drug, other reasons including maternal request.
Maricopa Medical Center - District Medical Group, Phoenix
Precision Trials, Phoenix
Phoenix Perinatal Associates (Scottsdale Healthcare Shea), Scottsdale
Watching Over Mothers and Babies Foundation, Tucson
Miller's Childrens Hospital, Long Beach
UCI Medical Center, Orange
The Women's Clinic of Northern Colorado, Fort Collins
Christiana Care Health System (DE Center for MFM), Newark
University of FL College of Medicine, Jacksonville
Altus Research, Lake Worth
University of South Florida, Tampa
Indiana University School of Medicine, Indianapolis
University of Kansas School of Medicine, Kansas City
University of Michigan Hospital, Ann Arbor
Spectrum Health, Grand Rapids
St. Louis University, St Louis
St. Peters University Hospital, New Brunswick
University of New Mexico/New Mexico Health Science Center, Albuquerque
Duke University Medical Center, Durham
East Carolina University, Brody School of Medicine, Greenville
Lyndhurst Gynecologic Associates, Winston-Salem
University of Cincinnati, Cincinnati
Clinical Trials of America, Eugene
Drexel University College of Medicine, Philadelphia
Temple University School of Medicine, Philadelphia
Thomas Jefferson University, Philadelphia
Medical University of South Carolina, Charleston
University Medical Group/Greenville Hospital System, Greenville
UT College of Medicine Chattanooga, Erlanger Health System, Chattanooga
High Risk Obstetrical Consultants, PLLC, Knoxville
Research Memphis Associates, Memphis
University of Texas Health Sciences Center at Houston, Houston
Salt Lake Women's Center, PC, Sandy City
Marshfield Clinic Research Foundation, Marshfield
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY